{"name":"Johnson & Johnson Development","permalink":"johnson-johnson-development","crunchbase_url":"http://www.crunchbase.com/financial-organization/johnson-johnson-development","homepage_url":"http://www.jjdevcorp.com","blog_url":"","blog_feed_url":"","twitter_username":null,"phone_number":"","description":null,"email_address":"","number_of_employees":null,"founded_year":1973,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Thu Jan 01 04:59:19 UTC 2009","updated_at":"Thu Jan 01 05:01:46 UTC 2009","overview":"<p>Organized in 1973, Johnson &amp; Johnson Development Corporation (JJDC) is the venture capital subsidiary of Johnson &amp; Johnson. JJDC makes private equity investments in venture funded health care companies. Portfolio companies include those in the fields of pharmaceuticals, biotechnology, medical devices, diagnostics and consumer products. JJDC also leads and manages internal investments in selected promising technologies.</p>","image":{"available_sizes":[[[150,61],"assets/images/resized/0003/2806/32806v1-max-150x150.png"],[[206,85],"assets/images/resized/0003/2806/32806v1-max-250x250.png"],[[206,85],"assets/images/resized/0003/2806/32806v1-max-450x450.png"]],"attribution":null},"offices":[{"description":"","address1":"","address2":"","zip_code":"","city":"New Brunswick","state_code":"NJ","country_code":"USA","latitude":null,"longitude":null}],"relationships":[],"investments":[{"funding_round":{"round_code":"a","source_url":"http://www.equityhelpdesk.com/PrivateEquity/Neuron_Systems_Raises_First_Round","source_description":"Equity Help Desk","raised_amount":8960000,"raised_currency_code":"USD","funded_year":2008,"funded_month":8,"funded_day":8,"company":{"name":"Neuron Systems","permalink":"neuron-systems","image":{"available_sizes":[[[150,36],"assets/images/resized/0004/1194/41194v1-max-150x150.png"],[[250,61],"assets/images/resized/0004/1194/41194v1-max-250x250.png"],[[264,65],"assets/images/resized/0004/1194/41194v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.brainsgate.com/eng/inthenews.php?actions=details&id=29","source_description":"BrainsGate raises $27.5m","raised_amount":27500000,"raised_currency_code":"USD","funded_year":2008,"funded_month":8,"funded_day":13,"company":{"name":"Brainsgate","permalink":"brainsgate","image":{"available_sizes":[[[150,62],"assets/images/resized/0005/0318/50318v1-max-150x150.jpg"],[[173,72],"assets/images/resized/0005/0318/50318v1-max-250x250.jpg"],[[173,72],"assets/images/resized/0005/0318/50318v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"f","source_url":"http://onbiovc.com/iscience-interventional-inc-series-f-205m/","source_description":"iScience Interventional, Inc.: Series F $20.5M","raised_amount":20500000,"raised_currency_code":"USD","funded_year":2009,"funded_month":5,"funded_day":5,"company":{"name":"iScience Interventional","permalink":"iscience-interventional","image":{"available_sizes":[[[150,88],"assets/images/resized/0005/0597/50597v1-max-150x150.jpg"],[[150,88],"assets/images/resized/0005/0597/50597v1-max-250x250.jpg"],[[150,88],"assets/images/resized/0005/0597/50597v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"e","source_url":"http://venturebeat.com/2008/02/27/insound-medical-takes-in-11m-for-invisible-hearing-aids/","source_description":"InSound Medical takes in $11M for â€œinvisibleâ€ hearing aids â€” albeit ones that have been on the shelf for a while","raised_amount":11000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":2,"funded_day":27,"company":{"name":"InSound Medical","permalink":"insound-medical","image":{"available_sizes":[[[131,59],"assets/images/resized/0005/2597/52597v1-max-150x150.jpg"],[[131,59],"assets/images/resized/0005/2597/52597v1-max-250x250.jpg"],[[131,59],"assets/images/resized/0005/2597/52597v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://deals.venturebeat.com/2009/10/05/direct-flow-medical-takes-40m-for-heart-valve-treatments/","source_description":"Direct Flow Medical takes $40M for heart valve treatments","raised_amount":40000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":10,"funded_day":5,"company":{"name":"Direct Flow Medical","permalink":"direct-flow-medical","image":{"available_sizes":[[[150,67],"assets/images/resized/0006/2095/62095v1-max-150x150.jpg"],[[250,112],"assets/images/resized/0006/2095/62095v1-max-250x250.jpg"],[[335,151],"assets/images/resized/0006/2095/62095v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"f","source_url":"http://onbiovc.com/sleep-solutions-inc-series-f-20m/","source_description":"Sleep Solutions, Inc.: Series F $20M","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":10,"funded_day":30,"company":{"name":"Sleep Solutions","permalink":"sleep-solutions","image":{"available_sizes":[[[150,26],"assets/images/resized/0006/4298/64298v1-max-150x150.jpg"],[[250,44],"assets/images/resized/0006/4298/64298v1-max-250x250.jpg"],[[342,61],"assets/images/resized/0006/4298/64298v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://onbiovc.com/celladon-inc-series-c-218m/","source_description":"Celladon, Inc.: Series C $21.8M","raised_amount":21800000,"raised_currency_code":"USD","funded_year":2009,"funded_month":11,"funded_day":1,"company":{"name":"Celladon","permalink":"celladon","image":{"available_sizes":[[[150,19],"assets/images/resized/0006/4625/64625v1-max-150x150.jpg"],[[250,33],"assets/images/resized/0006/4625/64625v1-max-250x250.jpg"],[[338,45],"assets/images/resized/0006/4625/64625v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://deals.venturebeat.com/2009/11/09/spinal-modulation-raises-27m-to-treat-spinal-pain/","source_description":"Spinal Modulation raises $27M to treat spinal pain","raised_amount":27400000,"raised_currency_code":"USD","funded_year":2009,"funded_month":11,"funded_day":9,"company":{"name":"Spinal Modulation","permalink":"spinal-modulation","image":{"available_sizes":[[[150,36],"assets/images/resized/0008/4884/84884v1-max-150x150.jpg"],[[250,60],"assets/images/resized/0008/4884/84884v1-max-250x250.jpg"],[[398,97],"assets/images/resized/0008/4884/84884v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=29&aid=DJFVLS0020091216e5cg00001&r=Rss&s=DJFVLS","source_description":"Swiss Protein Therapy Co. Molecular Partners Pulls In $44M Series B  ","raised_amount":44200000,"raised_currency_code":"USD","funded_year":2009,"funded_month":12,"funded_day":16,"company":{"name":"Molecular Partners","permalink":"molecular-partners","image":{"available_sizes":[[[150,49],"assets/images/resized/0007/0288/70288v1-max-150x150.jpg"],[[185,61],"assets/images/resized/0007/0288/70288v1-max-250x250.jpg"],[[185,61],"assets/images/resized/0007/0288/70288v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2010/01/phasebio-pharmaceuticals-raises.html","source_description":"PhaseBio Pharmaceuticals Raises $25M in Series B Funding Round","raised_amount":25000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":1,"funded_day":7,"company":{"name":"PhaseBio Pharmaceuticals","permalink":"phasebio-pharmaceuticals","image":{"available_sizes":[[[150,49],"assets/images/resized/0007/2629/72629v1-max-150x150.jpg"],[[193,64],"assets/images/resized/0007/2629/72629v1-max-250x250.jpg"],[[193,64],"assets/images/resized/0007/2629/72629v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.tengion.com/news/press/20071015.cfm","source_description":"Tengion Closes $33 Million in Series C Funding Deerfield Partners Joins Investor Group as Company Advances Novel Regenerative Medicine Products","raised_amount":33000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":10,"funded_day":15,"company":{"name":"Tengion","permalink":"tengion","image":{"available_sizes":[[[150,31],"assets/images/resized/0007/9906/79906v1-max-150x150.jpg"],[[250,52],"assets/images/resized/0007/9906/79906v1-max-250x250.jpg"],[[289,61],"assets/images/resized/0007/9906/79906v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.syntaxin.com/biopharma-news-article.php?id=39","source_description":"Syntaxin Raises $32M to Advance Development of Novel Drug Pipeline","raised_amount":32000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":10,"funded_day":31,"company":{"name":"Syntaxin","permalink":"syntaxin","image":{"available_sizes":[[[150,64],"assets/images/resized/0008/0047/80047v1-max-150x150.jpg"],[[182,78],"assets/images/resized/0008/0047/80047v1-max-250x250.jpg"],[[182,78],"assets/images/resized/0008/0047/80047v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://biolex.com/pdfs/Biolex%20-%20Series%20C%20Press%20Release%20-%20May%2024,%202007.pdf","source_description":"BIOLEX THERAPEUTICS RAISES $30 MILLION TO ADVANCE ITS HEPATITIS C DRUG CANDIDATE AND OTHER PIPELINE PROGRAMS","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":5,"funded_day":24,"company":{"name":"Biolex Therapeutics","permalink":"biolex-therapeutics","image":{"available_sizes":[[[150,50],"assets/images/resized/0005/0190/50190v1-max-150x150.png"],[[250,84],"assets/images/resized/0005/0190/50190v1-max-250x250.png"],[[263,89],"assets/images/resized/0005/0190/50190v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.axialbiotech.com/company/find/press/2007/5","source_description":"Axial Biotech Announces $15.3 Million Series B Financing","raised_amount":15300000,"raised_currency_code":"USD","funded_year":2007,"funded_month":3,"funded_day":27,"company":{"name":"Axial Biotech","permalink":"axial-biotech","image":{"available_sizes":[[[150,92],"assets/images/resized/0008/0109/80109v1-max-150x150.jpg"],[[165,102],"assets/images/resized/0008/0109/80109v1-max-250x250.jpg"],[[165,102],"assets/images/resized/0008/0109/80109v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://olv.duke.edu/About/News/20071025085536830","source_description":"Phase Bioscience raises $6.6 million","raised_amount":6600000,"raised_currency_code":"USD","funded_year":2007,"funded_month":10,"funded_day":24,"company":{"name":"PhaseBio Pharmaceuticals","permalink":"phasebio-pharmaceuticals","image":{"available_sizes":[[[150,49],"assets/images/resized/0007/2629/72629v1-max-150x150.jpg"],[[193,64],"assets/images/resized/0007/2629/72629v1-max-250x250.jpg"],[[193,64],"assets/images/resized/0007/2629/72629v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.tengion.com/news/press/20060623.cfm","source_description":"Tengion Inc. Completes $50 Million Series \"B\" Round Financing led by Bain Capital and Quaker BioVentures will support neo-bladder clinical trials, manufacturing capacity and pipeline development","raised_amount":50000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":6,"funded_day":23,"company":{"name":"Tengion","permalink":"tengion","image":{"available_sizes":[[[150,31],"assets/images/resized/0007/9906/79906v1-max-150x150.jpg"],[[250,52],"assets/images/resized/0007/9906/79906v1-max-250x250.jpg"],[[289,61],"assets/images/resized/0007/9906/79906v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.aqxpharma.com/news/news-20100617.html","source_description":"Aquinox Pharmaceuticals completes US $25 million Series B financing","raised_amount":25000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":6,"funded_day":17,"company":{"name":"Aquinox Pharmaceuticals","permalink":"aquinox-pharmaceuticals","image":{"available_sizes":[[[150,56],"assets/images/resized/0009/1000/91000v1-max-150x150.jpg"],[[200,75],"assets/images/resized/0009/1000/91000v1-max-250x250.jpg"],[[200,75],"assets/images/resized/0009/1000/91000v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.lsoncology.com/press_releases/release/pr_1206666394","source_description":"LIGHT SCIENCES ONCOLOGY COMPLETES SECOND CLOSING IN $67 MILLION FINANCING FOR LATE STAGE DEVELOPMENT OF LITXâ„¢ AND ANNOUNCES ADDITIONAL DIRECTORS","raised_amount":67000000,"raised_currency_code":"USD","funded_year":2005,"funded_month":12,"funded_day":14,"company":{"name":"Light Sciences Oncology","permalink":"light-sciences-oncology","image":{"available_sizes":[[[150,39],"assets/images/resized/0006/5310/65310v1-max-150x150.png"],[[244,65],"assets/images/resized/0006/5310/65310v1-max-250x250.png"],[[244,65],"assets/images/resized/0006/5310/65310v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=32&aid=DJFVW00020101014e6ae000b7&r=Rss&s=DJFVW","source_description":"Johnson & Johnson Backs Intio In $8.1M Series B Round  ","raised_amount":8100000,"raised_currency_code":"USD","funded_year":2010,"funded_month":10,"funded_day":14,"company":{"name":"Intio","permalink":"intio","image":{"available_sizes":[[[150,67],"assets/images/resized/0010/6332/106332v1-max-150x150.jpg"],[[225,101],"assets/images/resized/0010/6332/106332v1-max-250x250.jpg"],[[225,101],"assets/images/resized/0010/6332/106332v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.fiercebiotech.com/story/vcs-inject-29m-syntaxin-115m-ceregene/2010-11-11?utm_medium=rss&utm_source=rss","source_description":"VCs inject $29M into Syntaxin, $11.5M into Ceregene","raised_amount":29000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":11,"funded_day":11,"company":{"name":"Syntaxin","permalink":"syntaxin","image":{"available_sizes":[[[150,64],"assets/images/resized/0008/0047/80047v1-max-150x150.jpg"],[[182,78],"assets/images/resized/0008/0047/80047v1-max-250x250.jpg"],[[182,78],"assets/images/resized/0008/0047/80047v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2011/01/genocea-biosciences-closes-35m-series-b.html","source_description":"Genocea Biosciences Closes $35M Series B Financing Round","raised_amount":35000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":1,"funded_day":3,"company":{"name":"Genocea Biosciences","permalink":"genocea-biosciences","image":{"available_sizes":[[[150,63],"assets/images/resized/0009/8416/98416v1-max-150x150.png"],[[250,106],"assets/images/resized/0009/8416/98416v1-max-250x250.png"],[[256,109],"assets/images/resized/0009/8416/98416v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.finsmes.com/2011/01/zeo-receives-123m-third-financing.html","source_description":"Zeo Receives $12.3M Third Financing","raised_amount":12338500,"raised_currency_code":"USD","funded_year":2011,"funded_month":1,"funded_day":6,"company":{"name":"Zeo","permalink":"zeo","image":{"available_sizes":[[[108,87],"assets/images/resized/0006/9802/69802v2-max-150x150.png"],[[108,87],"assets/images/resized/0006/9802/69802v2-max-250x250.png"],[[108,87],"assets/images/resized/0006/9802/69802v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://techcrunch.com/2011/01/07/johnson-johnson-leads-9-million-investment-in-personal-genetics-startup-23andme/","source_description":"Johnson & Johnson Leads $9 Million Investment In Personal Genetics Startup 23andMe","raised_amount":9000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":1,"funded_day":7,"company":{"name":"23andMe","permalink":"23andme","image":{"available_sizes":[[[105,72],"assets/images/resized/0000/1291/1291v3-max-150x150.png"],[[105,72],"assets/images/resized/0000/1291/1291v3-max-250x250.png"],[[105,72],"assets/images/resized/0000/1291/1291v3-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.businesswire.com/news/home/20110615005661/en/Spinal-Modulation-Secures-30-Million-Series-Financing","source_description":"Spinal Modulation Secures $30 Million Series D Financing","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":6,"funded_day":15,"company":{"name":"Spinal Modulation","permalink":"spinal-modulation","image":{"available_sizes":[[[150,36],"assets/images/resized/0008/4884/84884v1-max-150x150.jpg"],[[250,60],"assets/images/resized/0008/4884/84884v1-max-250x250.jpg"],[[398,97],"assets/images/resized/0008/4884/84884v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.atlasgenetics.com/press/18_jul_2011.html","source_description":"Atlas Genetics Ltd Completes Â£16.9 million Series B Financing led by Novartis Venture Funds","raised_amount":16900000,"raised_currency_code":"GBP","funded_year":2011,"funded_month":7,"funded_day":18,"company":{"name":"Atlas Genetics","permalink":"atlas-genetics","image":{"available_sizes":[[[150,67],"assets/images/resized/0014/5408/145408v2-max-150x150.jpg"],[[197,89],"assets/images/resized/0014/5408/145408v2-max-250x250.jpg"],[[197,89],"assets/images/resized/0014/5408/145408v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.finsmes.com/2012/01/powervision-receives-12-5m-investment-jjdc-series.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"PowerVision Receives $12.5M Investment from JJDC in Series C Round","raised_amount":12500000,"raised_currency_code":"USD","funded_year":2012,"funded_month":1,"funded_day":23,"company":{"name":"PowerVision","permalink":"powervision","image":{"available_sizes":[[[150,84],"assets/images/resized/0003/4427/34427v1-max-150x150.png"],[[250,140],"assets/images/resized/0003/4427/34427v1-max-250x250.png"],[[385,216],"assets/images/resized/0003/4427/34427v1-max-450x450.png"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}